FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003064008> ?p ?o ?g. }

• W2003064008 endingPage "664" @default.
• W2003064008 startingPage "655" @default.
• W2003064008 abstract "Objective: The expression of connective tissue growth factor mRNA in human kidneys may serve as an early marker for lupus nephritis progression. Therefore, we speculated that connective tissue growth factor may be involved in the pathogenesis of systemic lupus erythematosus and lupus nephritis. In this study, we set out to investigate the associations between serum connective tissue growth factor levels and clinicopathological features of patients with systemic lupus erythematosus and lupus nephritis. Methods: Serum samples from patients with non-renal systemic lupus erythematosus, renal biopsy-proven lupus nephritis and healthy control subjects were detected by enzyme-linked immunosorbent assay for serum connective tissue growth factor levels. The associations between connective tissue growth factor levels and clinicopathological features of the patients were further analysed. Results: The levels of serum connective tissue growth factor in patients with non-renal systemic lupus erythematosus and lupus nephritis were both significantly higher than those in the normal control group (34.14 ± 12.17 ng/ml vs. 22.8 ± 3.0 ng/ml, p<0.001; 44.1 ± 46.8 ng/ml vs. 22.8 ± 3.0 ng/ml, p = 0.035, respectively). There was no significant difference of the serum connective tissue growth factor levels between non-renal systemic lupus erythematosus and lupus nephritis group (34.14 ± 12.17 ng/ml vs. 44.1 ± 46.8 ng/ml, p = 0.183). Serum connective tissue growth factor levels were significantly higher in lupus nephritis patients with the following clinical manifestations, including anaemia (51.3 ± 51.4 ng/ml vs. 23.4 ± 9.7 ng/ml, p<0.001) and acute renal failure (85.5 ± 75.0 ng/ml vs. 31.2 ± 21.8 ng/ml, p = 0.002). Serum connective tissue growth factor levels in class IV were significantly higher than that in class II, III and V (57.6 ± 57.5 ng/ml vs. 18.7 ± 6.4 ng/ml, p = 0.019; 57.6 ± 57.5 ng/ml vs. 25.2 ± 14.9 ng/ml, p = 0.006; 57.6 ± 57.5 ng/ml vs. 30.5 ± 21.3 ng/ml, p = 0.017, respectively). Serum connective tissue growth factor levels were significantly higher in those with both active/chronic lesions than those in those with active lesions only in either class IV (84.9 ± 69.6 ng/ml vs. 40.0 ± 40.2 ng/ml, p = 0.001) or in combination of class III and IV lupus nephritis (63.3 ± 63.4 ng/ml vs. 38.3 ± 37.9 ng/ml, p = 0.035, respectively). Serum connective tissue growth factor levels were negatively associated with estimated glomerular filtration rate (r = −0.46, p<0.001) and positively associated with interstitial inflammation (r = 0.309, p = 0.002) and interstitial fibrosis (r = 0.287, p = 0.004). Serum connective tissue growth factor level was a risk factor for doubling of serum creatinine in lupus nephritis ( p<0.001, hazard ratio = 1.015, 95% confidence intervals 1.008–1.022) in univariate analysis. Conclusions: Serum connective tissue growth factor levels were significantly higher in lupus and correlated with chronic renal interstitial injury and doubling of serum creatinine in patients with lupus nephritis." @default.
• W2003064008 created "2016-06-24" @default.
• W2003064008 creator A5008236609 @default.
• W2003064008 creator A5023531951 @default.
• W2003064008 creator A5061624427 @default.
• W2003064008 creator A5079014062 @default.
• W2003064008 creator A5082669026 @default.
• W2003064008 date "2014-02-17" @default.
• W2003064008 modified "2023-09-22" @default.
• W2003064008 title "The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and lupus nephritis" @default.
• W2003064008 cites W1961522814 @default.
• W2003064008 cites W1965683411 @default.
• W2003064008 cites W1975085088 @default.
• W2003064008 cites W1985878933 @default.
• W2003064008 cites W1995752760 @default.
• W2003064008 cites W2002331774 @default.
• W2003064008 cites W2005463323 @default.
• W2003064008 cites W2012524756 @default.
• W2003064008 cites W2013060765 @default.
• W2003064008 cites W2024685636 @default.
• W2003064008 cites W2026360811 @default.
• W2003064008 cites W2045458088 @default.
• W2003064008 cites W2059858674 @default.
• W2003064008 cites W2064999867 @default.
• W2003064008 cites W2068352185 @default.
• W2003064008 cites W2069369242 @default.
• W2003064008 cites W2070527591 @default.
• W2003064008 cites W2071299644 @default.
• W2003064008 cites W2072443528 @default.
• W2003064008 cites W2078017701 @default.
• W2003064008 cites W2086419185 @default.
• W2003064008 cites W2087394026 @default.
• W2003064008 cites W2092856791 @default.
• W2003064008 cites W2094404475 @default.
• W2003064008 cites W2097465080 @default.
• W2003064008 cites W2103865604 @default.
• W2003064008 cites W2116615394 @default.
• W2003064008 cites W2122603733 @default.
• W2003064008 cites W2128757614 @default.
• W2003064008 cites W2131684214 @default.
• W2003064008 cites W2134833299 @default.
• W2003064008 cites W2137759284 @default.
• W2003064008 cites W2138889351 @default.
• W2003064008 cites W2143173167 @default.
• W2003064008 cites W2148607908 @default.
• W2003064008 cites W2151051006 @default.
• W2003064008 cites W2154186340 @default.
• W2003064008 cites W2161024818 @default.
• W2003064008 cites W2169748382 @default.
• W2003064008 cites W2169804478 @default.
• W2003064008 cites W2170915377 @default.
• W2003064008 cites W4234944895 @default.
• W2003064008 cites W4238200498 @default.
• W2003064008 doi "https://doi.org/10.1177/0961203314524291" @default.
• W2003064008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24536044" @default.
• W2003064008 hasPublicationYear "2014" @default.
• W2003064008 type Work @default.
• W2003064008 sameAs 2003064008 @default.
• W2003064008 citedByCount "5" @default.
• W2003064008 countsByYear W20030640082015 @default.
• W2003064008 countsByYear W20030640082017 @default.
• W2003064008 countsByYear W20030640082019 @default.
• W2003064008 countsByYear W20030640082020 @default.
• W2003064008 countsByYear W20030640082023 @default.
• W2003064008 crossrefType "journal-article" @default.
• W2003064008 hasAuthorship W2003064008A5008236609 @default.
• W2003064008 hasAuthorship W2003064008A5023531951 @default.
• W2003064008 hasAuthorship W2003064008A5061624427 @default.
• W2003064008 hasAuthorship W2003064008A5079014062 @default.
• W2003064008 hasAuthorship W2003064008A5082669026 @default.
• W2003064008 hasConcept C126322002 @default.
• W2003064008 hasConcept C142724271 @default.
• W2003064008 hasConcept C159654299 @default.
• W2003064008 hasConcept C203014093 @default.
• W2003064008 hasConcept C2775915377 @default.
• W2003064008 hasConcept C2776670291 @default.
• W2003064008 hasConcept C2776912625 @default.
• W2003064008 hasConcept C2777058396 @default.
• W2003064008 hasConcept C2779075594 @default.
• W2003064008 hasConcept C2779134260 @default.
• W2003064008 hasConcept C2779912601 @default.
• W2003064008 hasConcept C2780091579 @default.
• W2003064008 hasConcept C2781087799 @default.
• W2003064008 hasConcept C518705261 @default.
• W2003064008 hasConcept C71924100 @default.
• W2003064008 hasConceptScore W2003064008C126322002 @default.
• W2003064008 hasConceptScore W2003064008C142724271 @default.
• W2003064008 hasConceptScore W2003064008C159654299 @default.
• W2003064008 hasConceptScore W2003064008C203014093 @default.
• W2003064008 hasConceptScore W2003064008C2775915377 @default.
• W2003064008 hasConceptScore W2003064008C2776670291 @default.
• W2003064008 hasConceptScore W2003064008C2776912625 @default.
• W2003064008 hasConceptScore W2003064008C2777058396 @default.
• W2003064008 hasConceptScore W2003064008C2779075594 @default.
• W2003064008 hasConceptScore W2003064008C2779134260 @default.
• W2003064008 hasConceptScore W2003064008C2779912601 @default.
• W2003064008 hasConceptScore W2003064008C2780091579 @default.
• W2003064008 hasConceptScore W2003064008C2781087799 @default.

• next